• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

RiverVest

edit

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.

Milestones

edit

• 
  RiverVest invested in Securus Medical Group. (8/1/11)
  Posted 8/1/11 at 10:00pm via finsmes.com
• 
  RiverVest invested in IDEV Technologies. (10/7/10)
  Posted 10/10/10 at 9:00pm via finsmes.com
• 
  RiverVest invested in Tryton Medical. (9/14/10)
  Posted 9/14/10 at 6:07pm via finsmes.com
• 
  RiverVest invested in Accumetrics. (9/1/10)
  Posted 9/7/10 at 5:58pm via finsmes.com
• 
  RiverVest invested in Otonomy. (8/30/10)
  Posted 8/30/10 at 9:20pm via otonomy.com
• 
  RiverVest invested in MacroGenics. (5/17/06)
  Posted 4/19/10 at 11:38pm via macrogenics.com
• 
  RiverVest invested in Excaliard Pharmaceuticals. (11/27/07)
  Posted 3/12/10 at 11:47pm via excaliard.com
• 
  RiverVest invested in Accumetrics. (1/21/10)
  Posted 1/22/10 at 4:15am via onbiovc.com
• 
  RiverVest invested in Salient Surgical Technologies. (1/7/10)
  Posted 1/8/10 at 1:31am via masshightech.com
• 
  RiverVest invested in Accumetrics. (2/21/08)
  Posted 7/12/09 at 11:10pm via prnewswire.com

Investments

Videos

Sources

1. Securus Medical Group Raises $750K in Series A Funding (finsmes.com) [edit]
2. IDEV Technologies Completes $46M Series D Financing (finsmes.com) [edit]
3. Tryton Medical Closes $20M Series D Round of Financing (finsmes.com) [edit]
4. Accumetrics Raises Additional $7M (finsmes.com) [edit]
5. Otonomy Closes $38.5 Million Series B Financing (otonomy.com) [edit]
6. Accumetrics, Inc.: Series E $16.6M (onbiovc.com) [edit]
7. Salient Surgical sews up $15M more in funding (masshightech.com) [edit]
8. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial (prnewswire.com) [edit]
9. Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners (excaliard.com) [edit]
10. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]